Cargando…

Symptom improvement is associated with serum cytokine level change during RTMS tretament in patients with treatment resistant depression

INTRODUCTION: Introduciton: Repetetive transcranial magnetic stimulation (rTMS) is an effective and safety noninvasive technique for treatment of major depression disorder (MDD). There is a body of increasing evidences on the potential molecular mechanisms underlying its effectivity even in case of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazary, J., Elemery, M., Kiss, S., Pogany, L., Faludi, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475696/ http://dx.doi.org/10.1192/j.eurpsy.2021.1315

Ejemplares similares

Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
por: Lazary, Judit, et al.
Publicado: (2021)

What is the link between the antidepressants, the transcranial magnetic stimulation and the peripheral vascular endothelial growth factor?
por: Lazáry, J., et al.
Publicado: (2022)

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
por: Elemery, Monika, et al.
Publicado: (2022)

Influence of Arabian Pharmacy on Diseases Tretament During Ottoman’s Period in Bosnia and Herzegovina
por: Skrbo, Armin, et al.
Publicado: (2017)

High-frequency rTMS in the treatment of depressive symptoms in schizophrenia: a neurophysiological profile of respondents and nonresponders
por: Kaleda, V., et al.
Publicado: (2022)

Emergency state in COVID-19 pandemic: Hungarian patients’ experiences
por: Pogany, L., et al.
Publicado: (2021)

Maternal bonding styles in smokers and non-smokers: a comparative study
por: Csala, Iren, et al.
Publicado: (2016)

A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression
por: Larini, L., et al.
Publicado: (2023)

rTMS efficacy in major depression disorder: comparing two reviews
por: Yasmine, S., et al.
Publicado: (2023)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples
por: Pogany, Laszlo, et al.
Publicado: (2021)

Changes in serum cytokine levels during induced whole body hyperthermia
por: Ahlers, O, et al.
Publicado: (1999)

Knowledge and attitudes toward repetitive transcranial magnetic stimulation (rTMS) as a treatment for postpartum and peripartum depression
por: Al-Shamali, H., et al.
Publicado: (2022)

Parcel-guided rTMS for depression
por: Moreno-Ortega, M., et al.
Publicado: (2020)

T209. TESTING CORTICAL RTMS TARGETS TO IMPROVE PSYCHOMOTOR SLOWING IN SCHIZOPHRENIA AND MAJOR DEPRESSION IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
por: Walther, Sebastian, et al.
Publicado: (2018)

Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen, Shaw-Ji, et al.
Publicado: (2013)

Longitudinal effects of rTMS on neuroplasticity in chronic treatment-resistant depression
por: Dalhuisen, Iris, et al.
Publicado: (2020)

PS103. Search for biomarkers for ketamine response from changes of cytokines in the patients with treatment resistant depression
por: Su, Tung-Ping, et al.
Publicado: (2016)

Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers
por: Lazary, Judit, et al.
Publicado: (2014)

Rumination symptoms in treatment-resistant major depressive disorder, and outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) treatment
por: Chu, Stephanie A., et al.
Publicado: (2023)

Serum soluble triggering receptor expressed on myeloid cells‐2 was not altered by rTMS in patients with treatment‐resistant depression
por: Tateishi, Hiroshi, et al.
Publicado: (2023)

Predicting Change in Depressive Symptoms in the Nursing Home
por: Reinhardt, Joann, et al.
Publicado: (2020)

Symposium Submission: rTMS and Schizophrenia: Recent Updates
Publicado: (2022)

Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression
por: Tateishi, Hiroshi, et al.
Publicado: (2019)

High-frequency rTMS improves quality of life and depressive symptoms in Parkinson’s disease: A case report
por: Michael, Panayiota, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation (rTMS) for catatonia– a case report
por: Licht, C., et al.
Publicado: (2022)

RTMS AND H7-COIL IN THE TREATMENT OF TINNITUS; MODIFIED PROTOCOL PRELIMINARY RESULTS
por: Geres, N., et al.
Publicado: (2023)

Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: a pilot study
por: Starkweather, Angela R, et al.
Publicado: (2014)

Effect of vortioxetine on proinflammatory cytokine levels in patients with heart failure and comorbid depression
por: Sikora, A., et al.
Publicado: (2021)

Bipolar Disorder - New era of Treatments: High dose Levothyroxine, rTMS and genetics
por: Zamar, A., et al.
Publicado: (2022)

Effectiveness of rTMS on Suicidal Thoughts in Patients With Depression
por: Bapakunhi, Dilshana Nafisa, et al.
Publicado: (2023)

Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression
por: Zou, Wei, et al.
Publicado: (2018)

The frequency-dependent stimulation effects of rTMS on the performance of problem-solving tasks and ongoing oscillations
por: Miyauchi, E., et al.
Publicado: (2022)

A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
por: Koutsomitros, Theodoros, et al.
Publicado: (2022)

Caregiver Depression, Change in the Severity of Neuropsychiatric Symptoms, and Subsequent Caregiver Abuse
por: Fang, Boye, et al.
Publicado: (2020)

Investigating Sequential and Simultaneous Changes in Trajectories of Cognitive Decline and Depressive Symptoms
por: Klee, Matthias, et al.
Publicado: (2021)

The Effects of Transitions in Caregiving and Changes in Social Participation on Old Adults’ Depressive Symptoms
por: Zhao, Xinyi, et al.
Publicado: (2020)

The Role of Social Connection/engagement Predicts Changes in Depressive Symptoms and IADL in Stroke
por: Elayoubi, Joanne, et al.
Publicado: (2021)

Predictors of clinical response after rTMS treatment of patients suffering from drug-resistant depression
por: Lacroix, Aurélie, et al.
Publicado: (2021)

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
por: Martinotti, Giovanni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g189rjmlckkbi29snc1921e9r1